Viruses have been evolving for millions of years, improving their ability to transfer genetic material to the hosts they infect.
“Neutralizing antibodies present in blood only contribute partially to protection.
Funding to drive Phase 1 and 1-2 Clinical Trials for COVID-19, HPV induced cancers and HBV Vaccine Candidates PHILADELPHIA, Penn., February 11, 2021
Vaccines are risky business. More than 90% fail during development, and manufacturers require legislated legal immunity to stay in business.